LivaNova (NASDAQ:LIVN) Rating Increased to Strong-Buy at KeyCorp

LivaNova (NASDAQ:LIVN) was upgraded by equities research analysts at KeyCorp to a “strong-buy” rating in a research note issued on Thursday,Zacks.com reports.

Several other equities analysts also recently commented on LIVN. Needham & Company LLC reissued a “buy” rating and issued a $64.00 price objective on shares of LivaNova in a research note on Wednesday, September 3rd. Barclays upped their price target on shares of LivaNova from $55.00 to $58.00 and gave the stock an “equal weight” rating in a report on Thursday, August 21st. Weiss Ratings reiterated a “sell (d+)” rating on shares of LivaNova in a research note on Monday. Robert W. Baird set a $75.00 price objective on LivaNova in a report on Tuesday. Finally, Mizuho upped their target price on LivaNova from $70.00 to $72.00 and gave the stock an “outperform” rating in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, LivaNova currently has a consensus rating of “Moderate Buy” and an average target price of $65.63.

LivaNova Stock Up 1.2%

LIVN stock opened at $62.82 on Thursday. The firm has a 50-day moving average price of $57.31 and a 200-day moving average price of $52.21. LivaNova has a 12 month low of $32.48 and a 12 month high of $65.57. The company has a current ratio of 1.33, a quick ratio of 1.12 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $3.43 billion, a P/E ratio of -15.70 and a beta of 1.02.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. GAMMA Investing LLC lifted its holdings in LivaNova by 182.5% during the 2nd quarter. GAMMA Investing LLC now owns 630 shares of the company’s stock worth $28,000 after buying an additional 407 shares during the period. State of Wyoming bought a new position in shares of LivaNova during the second quarter worth about $31,000. EverSource Wealth Advisors LLC raised its position in shares of LivaNova by 998.4% during the second quarter. EverSource Wealth Advisors LLC now owns 703 shares of the company’s stock worth $32,000 after acquiring an additional 639 shares during the last quarter. Quarry LP acquired a new position in shares of LivaNova in the third quarter worth approximately $36,000. Finally, UMB Bank n.a. lifted its stake in shares of LivaNova by 63.0% in the third quarter. UMB Bank n.a. now owns 792 shares of the company’s stock worth $41,000 after acquiring an additional 306 shares during the period. 97.64% of the stock is owned by institutional investors.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.